Sugi Predict

Sugi Predict / Compounds / SCHEMBL15060955

SCHEMBL15060955

SCHEMBL15060955

CCCCS(=O)(=O)c1ccc([N+](=O)[O-])cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.50
▸ KCNH2 Q12809 1/20 0.50
▸ CA1 P00915 5/20 0.49
▸ CA2 P00918 5/20 0.49
▸ CA12 O43570 4/20 0.49
▸ CA9 Q16790 4/20 0.49
▸ CA14 Q9ULX7 4/20 0.49
▸ CA3 P07451 3/20 0.49
▸ CA4 P22748 3/20 0.49
▸ CA6 P23280 3/20 0.49
▸ CA5A P35218 3/20 0.49
▸ CA7 P43166 3/20 0.49
▸ CA13 Q8N1Q1 3/20 0.49
▸ CA5B Q9Y2D0 3/20 0.49
▸ ALDH1A1 P00352 3/20 0.48
▸ CYP3A4 P08684 1/20 0.48
▸ CYP2C9 P11712 1/20 0.48
▸ CYP2C19 P33261 1/20 0.48
▸ MEN1 O00255 2/20 0.48
▸ KMT2A Q03164 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7537992 0.93 ALDH1A1 (0.56) MAPTKCNH2CA1CA2CA12
SCHEMBL17603652 0.93 ALDH1A1 (0.56) MAPTKCNH2CA1CA2CA12
SCHEMBL7541961 0.93 ALDH1A1 (0.56) MAPTKCNH2CA1CA2CA12
SCHEMBL30426244 0.93 ALDH1A1 (0.56) MAPTKCNH2CA1CA2CA12
SCHEMBL7538187 0.93 ALDH1A1 (0.56) MAPTKCNH2CA1CA2CA12
SCHEMBL11134832 0.93 ALDH1A1 (0.56) MAPTKCNH2CA1CA2CA12
SCHEMBL25118612 0.89 CA1 (0.52) MAPTCA1CA2CA12CA9
SCHEMBL19126866 0.85 CA2 (0.59) CA1CA2CA12CA9CA14
SCHEMBL2296287 0.83 CA1 (0.57) MAPTCA1CA2CA12CA9
SCHEMBL4161667 0.82 KMT2A (0.58) MAPTCA1CA2CA5AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117209545-A Preparation method of film containing IV group metal element and precursor composition thereof 大连恒坤新材料有限公司 2023-12-12 — — CN claimed
CN-116157551-A Silicon-based self-assembled monolayer composition and surface preparation using the same 乔治洛德方法研究和开发液化空气有限公司 2023-05-23 — — CN claimed
CN-117209545-B Preparation method of film containing IV group metal element and precursor composition thereof 大连恒坤新材料有限公司 2025-05-23 — — CN disclosed
CN-119213529-A Seamless and crack-free deposition 朗姆研究公司 2024-12-27 — — CN disclosed
CN-118402039-A Conformal deposition of silicon nitride 朗姆研究公司 2024-07-26 — — CN disclosed
CN-118402040-A Low temperature molybdenum deposition assisted by silicon-containing reactants 朗姆研究公司 2024-07-26 — — CN disclosed
CN-118355473-A Conformal carbon-doped silicon nitride films and methods thereof 朗姆研究公司 2024-07-16 — — CN disclosed
WO-2024064424-A1 GRAPH BASED MULTI-SURVEY HORIZON OPTIMIZATION LANDMARK GRAPHICS CORPORATION (US) 2024-03-28 — — WO disclosed
CN-117209545-A Preparation method of film containing IV group metal element and precursor composition thereof 大连恒坤新材料有限公司 2023-12-12 — — CN disclosed
CN-117121173-A Integration of fully aligned vias by selective deposition and resistivity reduction 朗姆研究公司 2023-11-24 — — CN disclosed
EP-3512604-B1 STABLE YELLOW IMIDAZOLIUM COMPOUNDS AND METHODS FOR THEIR USE WELLA OPERATIONS US LLC (US) 2023-05-31 — — EP disclosed
CN-116157551-A Silicon-based self-assembled monolayer composition and surface preparation using the same 乔治洛德方法研究和开发液化空气有限公司 2023-05-23 — — CN disclosed
US-20180066007-A1 Macrocyclic Compounds And Methods Of Making And Using The Same BioVersys AG (CH) 2018-03-08 — — US disclosed
US-20170349621-A1 TRIAZOLE COMPOUNDS AND METHODS OF MAKING AND USING THE SAME BioVersys AG (CH) 2017-12-07 — — US disclosed
US-20160152654-A1 TRIAZOLE COMPOUNDS AND METHODS OF MAKING AND USING THE SAME BioVersys AG (CH) 2016-06-02 — — US disclosed
US-9085600-B2 Triazole compounds and methods of making and using the same MELINTA THERAPEUTICS, INC. (US) 2015-07-21 — — US disclosed
US-20140094422-A1 Triazole Compounds and Methods of Making and Using the Same SILICON VALLEY BANK 2014-04-03 — — US disclosed
US-8470985-B2 Triazole compounds and methods of making and using the same RIB-X PHARMACEUTICALS, INC. (US) 2013-06-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170349621-A1 TRIAZOLE COMPOUNDS AND METHODS OF MAKING AND USING THE SAME PROKR1, ARG1, ARG2 MAPT 4213/4885KCNH2 3850/4885CA1 3502/4885
US-20180066007-A1 Macrocyclic Compounds And Methods Of Making And Using The Same CCNO, PTGDR, CCNE1 MAPT 4552/4885KCNH2 2769/4885CA1 1794/4885
US-20140094422-A1 Triazole Compounds and Methods of Making and Using the Same PROKR1, ARG1, ARG2 MAPT 4213/4885KCNH2 3850/4885CA1 3502/4885
US-20160152654-A1 TRIAZOLE COMPOUNDS AND METHODS OF MAKING AND USING THE SAME PROKR1, ARG1, ARG2 MAPT 4213/4885KCNH2 3850/4885CA1 3502/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.